By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ThromboGenics NV 

Gaston Geenslaan 1

Heverlee    B-3001  Belgium
Phone: 32-0-16-751310 Fax: 32-0-16-751311


SEARCH JOBS








Company News
ThromboGenics NV (TBGNF) Receives US FDA Approval For New 'Already-Diluted' Formulation Of JETREA 6/8/2016 10:11:31 AM
ThromboGenics NV (TBGNF) Business Update - Q1 2016 5/13/2016 9:51:26 AM
ThromboGenics NV (TBGNF) Release: New Ocriplasmin Research Findings Presented At Upcoming Association for Research in Vision & Ophthalmology 2016 Annual Meeting In Seattle 4/27/2016 8:37:34 AM
ThromboGenics NV (TBGNF) Release: New Ocriplasmin Research Findings Presented 4/27/2016 7:39:30 AM
ThromboGenics NV (TBGNF) To Host R&D Investor Meeting On Novel Disease-Modifying Approaches For Diabetic Eye Disease In London Today 3/18/2016 9:54:00 AM
ThromboGenics NV (TBGNF) To Host R&D Investor Meeting On Novel Disease-Modifying Approaches For Diabetic Eye Disease 18 March In London 3/1/2016 10:35:34 AM
ThromboGenics NV (TBGNF) and VIB Form New Company to Research Roche (RHHBY)-Rejected Cancer Drug 4/16/2015 6:56:01 AM
ThromboGenics NV (TBGNF) Announces Positive Topline Results From OASIS Study 3/24/2015 7:33:07 AM
ThromboGenics NV (TBGNF)'s JETREA Gains Approval In Brazil 3/16/2015 7:24:26 AM
ThromboGenics NV (TBGNF) Full Year 2014 Business Update 3/13/2015 7:16:52 AM
12345678
//-->